Navigation Links
AcelRx Pharmaceuticals Provides Clinical Trial Updates
Date:2/19/2013

he study is designed to assess the ability of sufentanil, delivered through the NanoTab System to control moderate-to-severe post-operative pain over 48 to 72 hours compared to a placebo delivered through the NanoTab System.  The study will also assess the tolerability, safety, and ease of use of the NanoTab System by nurses and patients.  Top-line results are expected in the first quarter of 2013. 
  • A second placebo-controlled Phase 3 trial with the Sufentanil NanoTab PCA System is being conducted at approximately 32 sites in patients following hip or knee replacement surgery.   Targeting enrollment of approximately 400 patients, dosing of the final subject in this study is expected around the end of the first quarter of 2013.  The primary endpoint for both the abdominal and orthopedic placebo-controlled Phase 3 studies is the sum of pain intensity difference to baseline (SPID) over 48 hours. Top-line results should be available for the orthopedic study during the second quarter of 2013.
  • Dosing of the last patient in a Phase 2, placebo-controlled, dose-finding study of the Company's ARX-04 sufentanil NanoTab product has completed.  This study, which began in November 2012, enrolled 101 patients following bunionectomy surgery, randomized into one of three groups: 20 mcg sufentanil NanoTab, 30 mcg sufentanil NanoTab or placebo.  Each dose was administered by healthcare personnel, as requested by the patient, up to a maximum of one dose every hour.  The study is designed to evaluate the ability of sufentanil NanoTabs to manage moderate-to-severe acute pain over the first 12 hours following bunionectomy surgery.  ARX-04 is a sublingual sufentanil product candidate designed to provide a non-invasive, fast-onset treatment of patients with moderate-to-sever acute pain, both on the battlefield and in civilian settings of trauma or injury.  AcelRx is conducting the study at two sites with funding
    '/>"/>

  • SOURCE AcelRx Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
    2. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    3. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
    4. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
    5. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
    6. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
    7. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
    8. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
    9. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
    10. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
    11. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... , Sept. 22, 2014 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products, is ... Biomedical Inc. ("Thunderbird"), has signed a definitive lease agreement ... , BC.  The facility has 28,966 square feet ... 14,500 square feet of mezzanine space for a total ...
    (Date:9/22/2014)... Pa. , Sept. 22, 2014  Inovio ... today it has initiated a phase I clinical ... will evaluate the safety, tolerability, and immunogenicity of ... (HPV-6), which causes most aerodigestive cancers. ... throat, vocal cords, and parts of the esophagus ...
    (Date:9/22/2014)... NEW YORK , Sept. 22, ... has signed an exclusive, global license agreement with ... commercialization of its proprietary plasma fractionation process. Concurrently, ... and its intention to strategically refocus and rebrand ... plans to pursue a national listing for its ...
    Breaking Medicine Technology:T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6
    ... $300,000 as Title Sponsor of ZENPEP(R) CF Cycle for Life , ... BETHESDA, Md. , May 3 Thousands of cyclists will take ... tour in 18 cities across the country to support research to find new therapies and a ... San Francisco on June 26 . , ...
    ... American Pacific Corporation ( APFC) ("AMPAC") ... on Thursday, May 6, 2010 , immediately after the market closes, followed ... , , , ... invites you to participate in the teleconference to discuss the financial results ...
    Cached Medicine Technology:Cystic Fibrosis Foundation Launches National Cycling Series to Benefit Critical Research and Care 2Cystic Fibrosis Foundation Launches National Cycling Series to Benefit Critical Research and Care 3American Pacific to Release Financial Results and Hold Fiscal 2010 Second Quarter Investor Teleconference 2
    (Date:9/22/2014)... On Saturday, September 27, UHY LLP and UHY Cares ... is doing an amazing job helping kids and refurbishing school ... and friends will be spending the day at Academy of ... graphics, as well as clean the playground and surrounding park ... in May but due to weather conditions it was postponed ...
    (Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- Teens and young ... "intensive" behavioral counseling to help prevent risky sexual behaviors, ... Task Force. Every year, about 20 million new ... in the United States. About half involve people between ... force. Its new report, published Sept. 22 ...
    (Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
    (Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
    (Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
    Breaking Medicine News(10 mins):Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2
    ... Updated Information Provided to Customers , LANDOVER, Md., Jan. ... to pull products containing peanut butter and peanut paste ... has traced the salmonella to a plant owned by ... recalled products from our shelves including:, ...
    ... The association between tobacco smoke and cancer deaths ... by a recent study from a UC Davis researcher, ... lives than previously estimated. , The epidemiological analysis, published ... more than 70 percent of the cancer death burden ...
    ... /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... CEO. Terry is the current President and CEO of Shenzhen ... , a company targeted for a merger with HTDS. (See ... filings on Pink Sheets shortly. , Mr. Terry Yuan will ...
    ... to 50 million uninsuredsteeply rising insurance premiumsemployers cutting ... picture. In Disease, Diagnoses, and Dollars: Facing the ... Robert Kaplan takes America,s healthcare industry to task ... in it. , Provocative, timely, and comprehensively researched, ...
    ... MIAMI, Jan. 21 Financial services leader ING and the ... contest that,celebrates their success in the ING Run For Something ... The top three essays were submitted by ... Dade Middle School, 7th grade, -- Christian ...
    ... Favorite Body Parts: Our Faces are Fabulous; Tummies ... abs top the list of favorite and least favorite ... to a new survey conducted by American Laser Centers, ... U.S.Nearly a quarter of the men (24 percent) and ...
    Cached Medicine News:Health News:Giant Food Responds to Recall of Peanut Based Products 2Health News:UC Davis study links smoking with most male cancer deaths 2Health News:Hard To Treat Diseases (HTDS) To Name New CEO and Directors 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 3Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 4Health News:How Does Our Vanity Fare? 2
    The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
    Minimal M9CA Broth...
    Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
    ...
    Medicine Products: